1. Nanoparticles and Other Nanostructures and the Control of Pathogens: From Bench to Vaccines.
- Author
-
Boudier, Ariane and Le Faou, Alain
- Subjects
- *
PATHOGENIC microorganisms , *HEPATITIS associated antigen , *NANOPARTICLES , *CELL receptors , *MIDDLE East respiratory syndrome - Abstract
Parasites and microorganisms (protozoa, bacteria, and viruses) are still a concern despite progress in hygiene and anti-infectious therapy. To control viral infections, with AIDS and viral hepatitis B and C disregarded, only a limited number of antivirals are available for either chronic (e.g., herpes virus infections) or acute (e.g., influenza) infections, and in the case of acute episodes, they have to be administered as soon as possible or given for prevention. The administration of the tetravalent dengue vaccine, Dengvaxia SP ® sp (four chimeric vaccinal recombinant strains of I yellow fever virus i each expressing antigens of one of the four types of Dengue virus), is strictly limited to children aged from 9 to 16 years with laboratory-confirmed previous dengue virus infection and living in an endemic area [[10]]. The introduction of new pathogens or the spread of previously seldom described infections (e.g., viral zoonosis, Table 1) occurs continuously and some examples are briefly described below: - I Candida auris i : This emerging yeast, responsible for life-threatening infections, is in most cases resistant to anti-fungal treatment. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF